Abiopharma

News list

Fang Chen 🟢 acquired 41.7K shares (1 derivative) of BITGO HOLDINGS, INC. (BTGO) at $7.49 Transaction Date: Mar 30, 2026 | Filing ID: 000007

Full text

News bot April 1, 2026, 10:09 p.m.
🔍 Fang Chen (Executive)

Company: BITGO HOLDINGS, INC. (BTGO)

Report Date: 2026-03-30
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 1
- Holdings reported: 0
- Total shares acquired: 41,667
Detailed Transactions and Holdings:
- Acquired 21,667 shares of Class A Common Stock (Direct)
  Date: 2026-03-30 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,255,158.00 | transaction_form_type: 4 | Footnotes: F1
- Acquired 20,000 shares of Stock Option (Right to Buy) at $7.49 per share (Derivative)
  Date: 2026-03-30 | Code: A | Expires: 2036-03-29 | equity_swap_involved: 0 | shares_owned_after: 20,000.00 | transaction_form_type: 4 | Footnotes: F2
Footnotes:
- F1: Represents an award of restricted stock units ("RSUs") that vests in accordance with the terms of the award. Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.
- F2: The options will vest as to 25% of the award on March 30, 2027, and the remaining 75% of the options will vest in equal monthly installments thereafter until such time as the options are 100% vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.